Thrilled to share my dissertation work published in Diabetes, a research journal of the ADA 🧪: Critical assessment of indices used to assess beta-cell function diabetesjournals.org/diabetes/artic…

Our new research JNCI found that plasma NT-proBNP, a biomarker of heart failure🫀, was higher in cancer survivors than non-cancer adults. ↑NT-proBNP was linked with ↓survival, largely due to cardiac death. Dana-Farber’s Breast Oncology Center Dana-Farber Division of Population Sciences Dana-Farber academic.oup.com/jnci/article-a…

New study shows that higher blood levels of NT-proBNP were associated with a higher risk of cardiovascular mortality in cancer survivors, suggesting NT-proBNP could be a tool for monitoring cardiovascular health. #JenniferLigibel Chao Cao Erica Mayer dana-farber.org/newsroom/news-…

A recent JNCI📰 examined the association of N-terminal pro–brain natriuretic peptide with survival among US cancer survivors. Read it here🔽 pubmed.ncbi.nlm.nih.gov/38299668/ Chao Cao #JenniferLigibel Erica Mayer Ann Partridge MD, MPH

Our study Journal of Clinical Oncology found that > 1/4 cancer survivors had mobility disability 🚶‍♂️& ~10% had self-care disability🛁, which is more prevalent in patients undergoing treatment & racial/ethnic minorities and underserved groups. Dana-Farber’s Breast Oncology Center Dana-Farber Division of Population Sciences ascopubs.org/doi/10.1200/JC…

A study led by Dr Chao Cao (Chao Cao) & Dr Jennifer Ligibel found that 25% of cancer survivors grapple with significant disability post-diagnosis, highlighting the urgency for proactive disability prevention efforts. Learn more in Dana-Farber's Momentum👇 physicianresources.dana-farber.org/news/more-than…

More Than 25% of Cancer Survivors Report Significant Levels of Disability After Cancer Diagnosis, According to New Study Chao Cao Dana-Farber #oncology onclive.com/view/more-than…

More than one-fourth of cancer survivors reported having a physical disability that diminished their mobility, according to data published in Journal of Clinical Oncology. Healio spoke with Chao Cao of Dana-Farber about the study findings. Read more👇 bit.ly/3woJKlk

Thanks for highlighting our recent work reporting high prevalence of functional disabilities in US cancer survivors!

This week, we have an interesting article in JAMA which finds that adding three biomarkers that are clearly associated with cardiovascular disease to an existing risk equation does NOT improve the predictive ability of that equation. How does this happen? 🧵

#SABCS24 POSTER SESSION | P3-06-15 | Trajectories of Daily Step Counts in #BreastCancer Survivors in the Breast Cancer Weight Loss (BWEL) Trial. Chao Cao Olwen Hahn, MD Dawn Hershman Erica Mayer Vered Stearns Anna Weiss Clifford Hudis Eric Winer, MD Ann Partridge MD, MPH Lisa Carey, MD, ScM, FASCO

What an amazing breast oncology group! I feel very lucky to be surrounded by such incredible colleagues Dana-Farber’s Breast Oncology Center !

DFCI Young Adult Research Team What a Dream Team!! ❤️🔥 Ann Partridge MD, MPH Guilherme Nader Marta Dana-Farber’s Breast Oncology Center Kate E Dibble, Ph.D. Megan E. Tesch

Too much, too little, or just right? Read this new editorial by Chao Cao and Dr. Jennifer A. Ligibel of Dana-Farber on exercise triage pathways for patients with cancer: acsjournals.onlinelibrary.wiley.com/doi/10.1002/cn… OncoAlert #ExerciseOncology

Personalized molecular signatures of insulin resistance and type 2 diabetes. Great collaboration with Anna Krook & atul deshmukh and teams! A comprehensive clinically focused study of insulin signaling in skeletal muscle. 💪 Online Cell sciencedirect.com/science/articl…

For cancer survivors, a sedentary lifestyle may be associated with a higher risk of all-cause and cancer-specific mortality. JAMA Oncology Editor in Chief Mary L. (Nora) Disis, MD, explains the clinical impact of exercise.

Great opportunity to have a free personal trainer for 12 weeks and possibly reduce your risk of developing breast cancer.

Our latest piece highlighted the roles and future directions of all members of multidisciplinary exercise oncology team to ensure that cancer patients and survivors receive appropriate exercise training when, where and how they need it. Dana-Farber’s Breast Oncology Center academic.oup.com/jncimono/artic…

New research in JAMA Oncology from Dana-Farber’s Jennifer Ligibel, MD, shows a remote weight loss intervention helped breast cancer survivors significantly reduce their weight. Investigators will now evaluate if weight loss can help prevent breast cancer recurrence. Critical support

📰Check out the study design for #THRIVE65, a TeleHealth #ResistanceExercise intervention to preserve dose intensity and vitality in elder #BreastCancer patients. ❓The trial is poised to answer a crucial scientific question: Can exercise and nutrition support improve